Difference between revisions of "ICRP Glossary"
Jump to navigation
Jump to search
| Line 239: | Line 239: | ||
*[[Cobblestone area forming cell assay]] | *[[Cobblestone area forming cell assay]] | ||
| + | |||
| + | *[[Collective dose]] | ||
*[[Co-expertise]] | *[[Co-expertise]] | ||
| Line 599: | Line 601: | ||
*[[Genomic integrity]] | *[[Genomic integrity]] | ||
| + | |||
| + | *Geomagnetic cut-off rigidity (see [[Rigidity threshold]]) | ||
*[[Graded approach]] | *[[Graded approach]] | ||
| Line 609: | Line 613: | ||
*[[Gray]] (Gy) | *[[Gray]] (Gy) | ||
| + | |||
| + | *[[Ground-level enhancement]] | ||
*[[Growth fraction]] | *[[Growth fraction]] | ||
| Line 657: | Line 663: | ||
=== <big><span id="I">I</span></big> === | === <big><span id="I">I</span></big> === | ||
| + | |||
| + | *[[ICRU 4-element tissue]] | ||
| + | |||
| + | *[[ICRU sphere]] | ||
*[[Immune system]] | *[[Immune system]] | ||
| Line 687: | Line 697: | ||
*[[Institutional control]] | *[[Institutional control]] | ||
| + | |||
| + | *[[Intervention]] | ||
*[[Intensity-modulated radiotherapy]] | *[[Intensity-modulated radiotherapy]] | ||
| Line 735: | Line 747: | ||
*LET (see *[[Linear energy transfer]]) | *LET (see *[[Linear energy transfer]]) | ||
| + | |||
| + | *[[Licensee]] | ||
*[[Life Span Study]] | *[[Life Span Study]] | ||
| Line 821: | Line 835: | ||
=== <big><span id="N">N</span></big> === | === <big><span id="N">N</span></big> === | ||
| + | |||
| + | *[[National radon survey]] | ||
*[[National DRL]] | *[[National DRL]] | ||
| Line 835: | Line 851: | ||
*[[Noise]] | *[[Noise]] | ||
| + | |||
| + | *[[Nominal value]] | ||
*[[Nominal risk coefficient]] | *[[Nominal risk coefficient]] | ||
| Line 869: | Line 887: | ||
*[[Oncogene]] | *[[Oncogene]] | ||
| + | |||
| + | *[[Operating management]] | ||
| + | |||
| + | *[[Operational quantities]] | ||
*[[Optimisation]] | *[[Optimisation]] | ||
| + | |||
| + | *[[Optimisation of protection]] | ||
*[[Organ absorbed dose]] (see [[Organ/tissue absorbed dose]]) | *[[Organ absorbed dose]] (see [[Organ/tissue absorbed dose]]) | ||
| Line 933: | Line 957: | ||
*[[Practical radiological protection culture]] | *[[Practical radiological protection culture]] | ||
| + | |||
| + | *[[Practice]] | ||
*[[Prevailing circumstances]] | *[[Prevailing circumstances]] | ||
| Line 941: | Line 967: | ||
*[[Principle of optimisation]] | *[[Principle of optimisation]] | ||
| + | |||
| + | *[[Principles of protection]] | ||
*[[Procedural values]] | *[[Procedural values]] | ||
| Line 949: | Line 977: | ||
*[[Projected dose]] | *[[Projected dose]] | ||
| + | |||
| + | *[[Protection quantities]] | ||
*[[Protection strategy]] | *[[Protection strategy]] | ||
| Line 995: | Line 1,025: | ||
*[[Radioactive substance]] | *[[Radioactive substance]] | ||
| + | |||
| + | *[[Radioactive waste]] | ||
*[[Radioactivity]] | *[[Radioactivity]] | ||
| Line 1,001: | Line 1,033: | ||
*[[Radiographer]] | *[[Radiographer]] | ||
| + | |||
| + | *[[Radiological attack]] | ||
*[[Radiological controlled area]] | *[[Radiological controlled area]] | ||
| Line 1,013: | Line 1,047: | ||
*[[Radiosensitivity, cellular]] | *[[Radiosensitivity, cellular]] | ||
| + | |||
| + | *[[Radon progeny]] | ||
| + | |||
| + | *[[Radon-prone area]] | ||
*RAP (see [[Reference Animal and Plant]]) | *RAP (see [[Reference Animal and Plant]]) | ||
| Line 1,031: | Line 1,069: | ||
*[[Recovery (cellular or tissue)]] | *[[Recovery (cellular or tissue)]] | ||
| + | |||
| + | *[[Redox]] | ||
*[[Reference air kerma]] | *[[Reference air kerma]] | ||
| Line 1,055: | Line 1,095: | ||
*[[Reference phantom]] | *[[Reference phantom]] | ||
| + | |||
| + | *[[Reference value]] | ||
*[[Reference worker]] | *[[Reference worker]] | ||
| + | |||
| + | *[[Region]] | ||
*[[Regional diagnostic reference levels]] | *[[Regional diagnostic reference levels]] | ||
| Line 1,063: | Line 1,107: | ||
*REID (see [[Lifetime risk estimates]]) | *REID (see [[Lifetime risk estimates]]) | ||
| + | |||
| + | *[[Rigidity threshold]] | ||
*[[Rehabilitation of living conditions]] | *[[Rehabilitation of living conditions]] | ||
| Line 1,127: | Line 1,173: | ||
*[[Safety case]] | *[[Safety case]] | ||
| + | |||
| + | *[[Safety]] | ||
*[[Safety culture]] | *[[Safety culture]] | ||
*[[Scintigraphy]] | *[[Scintigraphy]] | ||
| + | |||
| + | *[[Sealed source]] | ||
*[[Secondary radiation]] | *[[Secondary radiation]] | ||
| + | |||
| + | *[[Security]] | ||
| + | |||
| + | *[[Security screening]] | ||
*SEE (see [[Specific effective energy]]] | *SEE (see [[Specific effective energy]]] | ||
| Line 1,141: | Line 1,195: | ||
*[[Severe deterministic injury]] | *[[Severe deterministic injury]] | ||
| + | |||
| + | *[[Sheltering]] | ||
*[[Shielding]] | *[[Shielding]] | ||
| Line 1,159: | Line 1,215: | ||
*[[Solar cycle]] | *[[Solar cycle]] | ||
| + | |||
| + | *[[Solar flare]] | ||
*[[Solar particle event]] | *[[Solar particle event]] | ||
| Line 1,173: | Line 1,231: | ||
*[[Source-related]] | *[[Source-related]] | ||
| + | |||
| + | *[[Source-related assessment]] | ||
*[[South Atlantic anomaly]] | *[[South Atlantic anomaly]] | ||
| Line 1,205: | Line 1,265: | ||
*[[Substantial radiation dose level]] | *[[Substantial radiation dose level]] | ||
| + | |||
| + | *[[Superposition principle]] (in dosimetry) | ||
*[[Supervised area]] | *[[Supervised area]] | ||
| + | |||
| + | *[[Surface contamination]] | ||
*[[Systemic model]] | *[[Systemic model]] | ||
| Line 1,233: | Line 1,297: | ||
*[[Tissue absorbed dose]] (see [[Organ/tissue absorbed dose]]) | *[[Tissue absorbed dose]] (see [[Organ/tissue absorbed dose]]) | ||
| + | |||
| + | *[[Thoron progeny]] | ||
*[[Thyroid blocking]] | *[[Thyroid blocking]] | ||
| Line 1,263: | Line 1,329: | ||
*[[Translocation]] | *[[Translocation]] | ||
| + | |||
| + | *[[Transmission detection system]] | ||
*[[Transparency]] | *[[Transparency]] | ||
| Line 1,273: | Line 1,341: | ||
*[[Treatment preparation in radiotherapy]] | *[[Treatment preparation in radiotherapy]] | ||
| + | |||
| + | *[[Trophic level]] | ||
*[[Types of materials]] | *[[Types of materials]] | ||
| Line 1,283: | Line 1,353: | ||
*[[Unsealed source]] | *[[Unsealed source]] | ||
| + | |||
| + | *[[Upper reference levels]] | ||
*[[Uptake]] | *[[Uptake]] | ||
| Line 1,301: | Line 1,373: | ||
*[[Waste disposal]] | *[[Waste disposal]] | ||
| + | |||
| + | *[[Waste management]] | ||
*[[Wisdom]] | *[[Wisdom]] | ||
| + | |||
| + | *WL (see [[Working level]]) | ||
| + | |||
| + | *WLM (see [[Working level month]]) | ||
| + | |||
| + | *[[Worker]] | ||
| + | |||
| + | *[[Working level]] | ||
| + | |||
| + | *[[Working level month]] | ||
*w<sub>T</sub> (see [[Tissue weighting factor]]) | *w<sub>T</sub> (see [[Tissue weighting factor]]) | ||
Revision as of 16:21, 28 March 2021
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. Some entries include historical descriptions to help readers better understand the term in a particular context.
It is a living document, updated regularly.
Many ICRP publications feature their own glossaries including, for example, highly specialized terms relevant to that specific publication or helpful for a reader to have close at hand, or when introducing new terms to be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
| 0-9 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ... |
0-9
- 4DCT (see Time-resolved computed tomography)
A
- Acute radiation sickness (see Acute radiation syndrome)
- ALI (see Annual limit on intake)
- AMAD (see Activity median aerodynamic diameter)
- Ambient dose equivalent, H*(10)
- ARS (see Acute radiation syndrome)
B
- BAT (see Best available techniques)
- Bcr/abl (see Breakpoint cluster region/abelson)
C
- CACA (see Cobblestone area forming cell assay)
- CAFC (see Cobblestone area forming cell assay)
- CBCT (see Cone beam computed tomography)
- Cobblestone area cell assay (see Cobblestone area forming cell assay)
- CR (see Concentration ratio)
D
- DAC (see Derived air concentration)
- DBT (see Digital breast tomosynthesis)
- DCRL (see Derived consideration reference level)
- DD (see Doubling dose)
- DDI, detector dose indicator (see Exposure index)
- DIL (see Derived investigation level)
- DDREF (see Dose and dose-rate effectiveness factor)
- Detector dose indicator (see Exposure index)
- Directional dose equivalent H’(d,Ω)
- DLP (see Dose-length product)
- Dose (of ionising radiation)
- DQE (see Detector quantum efficiency)
- DRL (see Diagnostic reference level)
E
- EAR (see Excess absolute risk)
- EI (see Exposure index)
- ELR (i.e. Excess Lifetime Risk, see Lifetime risk estimates)
- Endosteal tissue (see Endosteum)
- ERR (see Excess relative risk)
- Excess lifetime risk (see Lifetime risk estimates)
F
- Fluence, Φ
- FSU (see Functional subunits)
G
- GATA-2 (see GATA binding protein 2)
- Geomagnetic cut-off rigidity (see Rigidity threshold)
- Gray (Gy)
H
- HATM (see Human Alimentary Tract Model]
I
- IMRT (see Intensity-modulated radiotherapy)
- Incidence rate (see Incidence)
J
K
- Kerma, K
L
- LET (see *Linear energy transfer)
- LLE (see Lifetime risk estimates)
- Loss of Life Expectancy (see Lifetime risk estimates)
- LSS (see Life Span Study)
M
- MDCT (see Multi-detector computed tomography)
- MMD (see *Mass median diameter)
N
- NHEJ (see Non-homologous end joining)
O
- OAR (see Organ at risk)
- OEA (see Oxygen enhancement ratio)
P
- Particle fluence (see Fluence)
- Personal dose equivalent, Hp(d)
- PLDR (see Potentially lethal damage repair)
Q
- Quality factor, Q(L)
R
- Radiation detriment (see Detriment)
- RAP (see Reference Animal and Plant)
- RBE (see Relative biological effectiveness)
- Reference female (see Reference Individual)
- Reference male (see Reference Individual)
- REID (see Lifetime risk estimates)
- Response function (see Dose-response function)
- Risk of exposure-induced death (see (see Lifetime risk estimates)
- ROS (see Reactive oxygen species)
- RR (see Relative risk)
S
- S coefficient (radiation weighted) SW[(rT←rs)]
- SAF (see Specific absorbed fraction)
- SEE (see Specific effective energy]
- Sievert (Sv)
- SLDR (see Sublethal damage repair)
- Slice (in CT & CBCT)
- SOBP (see Spread-out Bragg peak)
- Source (see Radiation source)
- Superposition principle (in dosimetry)
T
- Transport of risk (see Transfer of risk)
U
V
W
- WL (see Working level)
- WLM (see Working level month)
- wT (see Tissue weighting factor)
- wR (see Radiation weighting factor)
X
Y
Z
...
- α/β ratio (see α/β value)
